Subcutaneous injection of water-soluble multi-walled carbon nanotubes in tumor-bearing mice boosts the host immune activity

Nanotechnology

Volumn 21, Issue 14, 2010, Pages

  Meng, Jie ^a   Yang, Man ^a   Jia, Fumin ^a   Kong, Hua ^a   Zhang, Weiqi ^a   Wang, Chaoying ^b   Xing, Jianmin ^c   Xie, Sishen ^b   Xu, Haiyan ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b INSTITUTE OF PHYSICS   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT SYSTEMS; HEPATOCARCINOMA; IMMUNE ACTIVITY; IMMUNE SYSTEMS; INFLAMMATORY CYTOKINES; MICE MODELS; TUMOR GROWTH;

ANTIGEN-ANTIBODY REACTIONS; BEARINGS (STRUCTURAL); MULTIWALLED CARBON NANOTUBES (MWCN); TUMORS; WATER INJECTION;

CARBON NANOTUBES;

CARBON NANOTUBE; COMPLEMENT COMPONENT C3; CYTOKINE; WATER;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL PROLIFERATION; CHEMISTRY; COMPLEMENT ACTIVATION; IMMUNITY; IMMUNOLOGY; MACROPHAGE; MOUSE; NEOPLASM; PATHOLOGY; PHAGOCYTOSIS; PROTEIN MICROARRAY; SECRETION; SOLUBILITY; SOLUTION AND SOLUBILITY; SUBCUTANEOUS DRUG ADMINISTRATION; ULTRASTRUCTURE;

ANIMALS; CELL PROLIFERATION; COMPLEMENT ACTIVATION; COMPLEMENT C3; CYTOKINES; IMMUNITY; INJECTIONS, SUBCUTANEOUS; MACROPHAGES; MICE; MICE, INBRED BALB C; NANOTUBES, CARBON; NEOPLASMS; ORGAN SPECIFICITY; PHAGOCYTOSIS; PROTEIN ARRAY ANALYSIS; SOLUBILITY; SOLUTIONS; WATER;

EID: 77949558466     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/21/14/145104     Document Type: Article

References (41)

1. Mintzer M A and Simanek E E 2009 Nonviral vectors for gene delivery Chem. Rev. 109 259-302
2. Lacerda L, Bianco A, Prato M and Kostarelos K 2008 Carbon nanotube cell translocation and delivery of nucleic acids in vitro and in vivo J. Mater. Chem. 18 17-22
3. Podesta J E, Al-Jamal K T, Herrero M A, Tian B, Ali-Boucetta H, Hegde V, Bianco A, Prato M and Kostarelos K 2009 Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model Small 5 1176-85
4. Liu Z, Winters M A, Holodniy M and Dai H 2007 siRNA delivery into human T cells and primary cells with carbon-nanotube transporters Angew. Chem. Int. Edn Engl. 46 2023-7
5. Singh R, Pantarotto D, McCarthy D, Chaloin O, Hoebeke J, Partidos C D, Briand J P, Prato M, Bianco A and Kostarelos K 2005 Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors J. Am. Chem. Soc. 127 4388-96
6. Kam N W, Liu Z and Dai H 2005 Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing J. Am. Chem. Soc. 127 12492-3
7. Yeh I C and Hummer G 2004 Nucleic acid transport through carbon nanotube membranes Proc. Natl Acad. Sci. USA 101 12177-82
8. Pantarotto D, Singh R, McCarthy D, Erhardt M, Briand J P, Prato M, Kostarelos K and Bianco A 2004 Functionalized carbon nanotubes for plasmid DNA gene delivery Angew. Chem. Int. Edn Engl. 43 5242-6
9. Zhang Z, Yang X, Zhang Y, Zeng B, Wang S, Zhu T, Roden R B, Chen Y and Yang R 2006 Delivery of telomerase reverse transcriptase small interfering RNA in complex with positively charged single-walled carbon nanotubes suppresses tumor growth Clin. Cancer Res. 12 4933-9
10. Murakami T, Sawada H, Tamura G, Yudasaka M, Iijima S and Tsuchida K 2008 Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy Nanomedicine 3 453-63
11. Liu Z, Chen K, Davis C, Sherlock S, Cao Q, Chen X and Dai H 2008 Drug delivery with carbon nanotubes for in vivo cancer treatment Cancer Res. 68 6652-60
12. Dhar S, Liu Z, Thomale J, Dai H and Lippard S J 2008 Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device J. Am. Chem. Soc. 130 11467-76
13. Wu W, Li R, Bian X, Zhu Z, Ding D, Li X, Jia Z, Jiang X and Hu Y 2009 Covalently combining carbon nanotubes with anticancer agent: preparation and antitumor activity ACS Nano 3 2740-50
14. Kam N W and Dai H 2005 Carbon nanotubes as intracellular protein transporters: generality and biological functionality J. Am. Chem. Soc. 127 6021-6
15. Shi Kam N W, Jessop T C, Wender P A and Dai H 2004 Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells J. Am. Chem. Soc. 126 6850-1
16. Meng J, Meng J, Duan J H, Kong H, Wang C, Xie S S, Chen S C, Xu H Y and Yang X D 2008 Carbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an anti-tumor immunotherapy Small 4 1364-70
17. Pantarotto D, Briand J P, Prato M and Bianco A 2004 Translocation of bioactive peptides across cell membranes by carbon nanotubes Chem. Commun. (Camb.) 7 16-7
18. Pantarotto D, Partidos C D, Graff R, Hoebeke J, Briand J P, Prato M and Bianco A 2003 Synthesis, structural characterization, and immunological properties of carbon nanotubes functionalized with peptides J. Am. Chemo. Soc. 125 6160-4
19. Pantarotto D, Partidos C D, Hoebeke J, Brown F, Kramer E, Briand J P, Muller S, Prato M and Bianco A 2003 Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses Chem. Biol. 10 961-6
20. Yandar N, Pastorin G, Prato M, Bianco A, Patarroyo M E and Manuel Lozano J 2008 Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model Vaccine 26 5864-73
21. Dobrovolskaia M A and McNeil S E 2007 Immunological properties of engineered nanomaterials Nat. Nanotechnol. 2 469-78
22. Simeonova P P and Erdely A 2009 Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers Inhal. Toxicol 21 68-73
23. Service R F 2003 Nanomaterials show signs of toxicity Science 300 243
24. Chou C C, Hsiao H Y, Hong Q S, Chen C H, Peng Y W, Chen H W and Yang P C 2008 Single-walled carbon nanotubes can induce pulmonary injury in mouse model Nano Lett. 8 437-45
25. Lam C W, James J T, McCluskey R and Hunter R L 2004 Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation Toxicol. Sci. 77 126-34
26. Nygaard U C, Hansen J S, Samuelsen M, Alberg T, Marioara C D and Løvik M 2009 Single-walled and multi-walled carbon nanotubes promote allergic immune responses in mice Toxicol. Sci. 109 113-23
27. Yang S T, Wang X, Jia G, Gu Y, Wang T, Nie H, Ge C, Wang H and Liu Y 2008 Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice Toxicol. Lett. 181 182-9
28. Schipper M L, Nakayama-Ratchford N, Davis C R, Kam N W, Chu P, Liu Z, Sun X, Dai H and Gambhir S S 2008 A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice Nat. Nanotechnol. 3 216-21
29. Meng J, Yang M, Song L, Kong H, Wang C Y, Wang R, Wang C, Xie S S and Xu H Y 2009 Concentration control of carbon nanotubes in aqueous solution and its influence on the growth behavior of fibroblasts Colloids Surf. B 71 148-53
30. Wang Q, Han Y, Wang Y, Qin Y and Guo Z-X 2008 Effect of surfactant structure on the stability of carbon nanotubes in aqueous solution J. Phys. Chem. B 112 7227-33
31. Liu Z, Cai W, He L, Nakayama N, Chen K, Sun X, Chen X and Dai H 2007 In vivo biodistribution and highly efficient tumor targeting of carbon nanotubes in mice Nat. Nanotechnol. 2 47-52
32. Murakami T, Sawada H, Tamura G, Yudasaka M, Iijima S and Tsuchida K 2008 Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy Nanomedicine 3 453-63
33. Salvador-Morales C, Flahaut E, Sim E, Sloan J, Green M L and Sim R B 2006 Complement activation and protein adsorption by carbon nanotubes Mol. Immun. 43 193-201
34. Hamad I, Christy Hunter A, Rutt K J, Liu Z, Dai H and Moein M S 2008 Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover Mol. Immun. 45 3797-803
35. Dobrovolskaia M A, Aggarwal P, Hall J B and McNeil S E 2008 Preclinical studies to understand nanoparticles interaction with the immune system and its potential effects on nanoparticles biodistribution Mol. Pharm. 5 487-95
36. Chanan-Khan A, Szebeni J, Savay S, Liebes L, Rafique N M, Alving C R and Muggia F M 2003 Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions Ann. Oncol. 14 1430-7
37. Chaudhuri D, Suriano R, Mittelman A and Tiwari R K 2009 Targeting the immune system in cancer Curr. Pharm. Biotechnol. 10 166-84
38. Dunkelberger J R and Song W C 2010 Complement and its role in innate and adaptive immune responses Cell Res. 20 34-50
39. Dranoff G 2004 Cytokines in cancer pathogenesis and cancer therapy Nat. Rev. Cancer 4 11-22
40. Klimp A H, de Vries E G, Scherphof G L and Daemen T 2002 A potential role of macrophage activation in the treatment of cancer Crit. Rev. Oncol. Hematol. 44 143-61
41. Fleetwood A J, Lawrence T, Hamilton J A and Cook A D 2007 Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for csf blockade in inflammation J. Immunol. 178 5245-52